← Back to Search

Biosynthetic Mesh

Phasix Mesh for Ventral Hernia

N/A
Waitlist Available
Led By Julie Holihan, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new type of mesh made from synthetic material to repair complex ventral hernias. It aims to see if this new mesh works better than current options like synthetic polypropylene mesh or sutures. The mesh helps by supporting the abdominal wall, allowing it to heal and reducing the risk of the hernia coming back. Hybrid mesh products have been designed to address the need for a cost-effective mesh leveraging the tensile strength of a synthetic mesh while minimizing the prosthetic footprint within the abdominal wall through resorbable materials.

Eligible Conditions
  • Ventral Hernia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Major complication free
Secondary study objectives
Clavien-Dindo complication grade
Cost Analysis
Emergency room visits
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Phasix MeshActive Control1 Intervention
Phasix mesh will be used in the repair of the hernia
Group II: Current CareActive Control1 Intervention
The hernia will be repaired with either synthetic mesh or suture repair, as determined by the operating surgeon.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
946 Previous Clinical Trials
344,289 Total Patients Enrolled
Julie Holihan, MDPrincipal InvestigatorUTHealth
2 Previous Clinical Trials
663 Total Patients Enrolled
~0 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top